In patients with recurrent or severe allergy to FFP, plasma-derived factor VIII concentrates, which contain trace amounts of ADAMTS-13, have been utilized [6,7], but the impact on ADAMTS-13 activity is marginal. Here, ADAMTS13 is linked to allergic disease.